# A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)

> **NCT02835794** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Florida**

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Omacetaxine
- **DRUG:** Azacitidine
- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT02835794
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding to support clinical trial
- **Last updated:** 2017-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02835794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02835794, "A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02835794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*